Download Adoption of recent amendments to joint food standards under the Australia New Zealand Food Standards Code Notice, Amendment No. 203, 204 and 205

Australian Amendment no. 203, 204 and 205. These amendments are to:

• permit the use of nicotinamide riboside chloride as a form of Vitamin B3 in foods for special medical purposes;
• permit the use of β-galactosidase (EC 3.2.1.23), an enzyme derived from a genetically modified organism to be used as a processing aid in lactose reduced dairy production.
• permit the use of a Steviol glycoside mixture, produced by fermentation from a genetically modified yarrowia lipolytica production strain, as an intense sweetener.
• permit the use of AOAC 2017.16 as a new method of analysis for total dietary fibre;
• permit the voluntary addition for 2’-fucosyllactose, produced via new genetically modified Escherichia coli BL21 strains in infant formula products (which includes infant formula, follow-on formula and infant formula products for special dietary uses) and formulated supplementary foods for young children; and
• permit a new source microorganism, being a genetically modified Bacillus licheniformis, for the permitted enzyme maltogenic alpha-amylase as a processing aid for use in brewing, manufacture of bakery products, the production of potable alcohol and starch processing.